Acerus Pharmaceuticals Co. (OTCMKTS:TRLPF – Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.22 and traded as high as $0.22. Acerus Pharmaceuticals shares last traded at $0.22, with a volume of 0 shares traded.
Acerus Pharmaceuticals Stock Performance
The stock has a market cap of $56.90 million, a P/E ratio of -2.75 and a beta of 2.60. The firm has a 50 day moving average of $0.22 and a two-hundred day moving average of $0.22. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.90 and a current ratio of 1.35.
Acerus Pharmaceuticals Company Profile
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.
See Also
- Five stocks we like better than Acerus Pharmaceuticals
- Stock Average Calculator
- These 2 Sectors Could Proivde Roadmap for the Market
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Stocks to Own if You Are Bearish on The Market
- How to Invest in Blue Chip Stocks
- Is Wingstop The Perfect Fast Casual Restaurant Model?
Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.